Anuh Pharma Ltd

Fri 23/10/2026,11:9:57 | NSE : ANUHPHR

₹76.00-2.87 (-3.64%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 80.38

Previous Close

₹ 78.87

Volume

25423

Mkt Cap ( ₹ Cr)

₹ 761.70

High

₹ 81.85

Low

₹ 75.60

52 Week High

₹ 99.50

52 Week Low

₹ 67.00

Book Value Per Share

₹ 36.28

Dividend Yield

1.89

Face Value

₹ 5.00

What's Your Call?

Collective community sentiment on Anuh Pharma Ltd

Your Vote -

Buy

85.71%

Hold

9.52%

Sell

4.76%

85.71%

21 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

57%

Sell Order Quantity

43%

Bid Price

Qty

76.97

12

77.00

4

77.00

24

77.00

55

77.00

208

Bid Total

27369

Bid Price

Qty

77.47

44

77.00

41

77.00

66

78.00

20

78.00

209

Bid Total

20696

Option Chain

Analyzes market sentiment, predicts Anuh Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anuh Pharma - Updates

    21 Oct 2026, 6:34PM Anuh Pharma Limited has informed the Exchange regarding 'receiving the possession of manufacturing facility'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - For Receiving The Possession Of Manufacturing Facility

    21 Oct 2026, 6:34PM Intimation for receiving the possession of manufacturing facility

  • Anuh Pharma has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    19 Oct 2026, 3:00PM As of September 2026, 71.80% is owned by Promoters and 28.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 71.78% and

  • Anuh Pharma - Agreements

    16 Oct 2026, 6:59PM Anuh Pharma Limited has informed the Exchange about signing of Asset Transfer Agreement

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    16 Oct 2026, 6:55PM Disclosure of Events under Regulation 30 of SEBI LODR Regulation, 2015 for signing of Asset Transfer Agreement

  • Anuh Pharma - Updates

    13 Oct 2026, 6:54PM Anuh Pharma Limited has informed the Exchange regarding 'proposal of Investment and availing of Loan'.

  • Anuh Pharma - Outcome of Board Meeting

    13 Oct 2026, 6:48PM Anuh Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on October 13, 2026 for Investment and availing of Loan.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Investment And Availing Of Loan

    13 Oct 2026, 6:42PM To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion

  • Anuh Pharma - Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 13/10/2026

    13 Oct 2026, 6:38PM To Consider and Approve for investment in manufacturing assets for expansion and proposal for availing of loan for expansion

  • Anuh Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    12 Oct 2026, 5:52PM Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anuh Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    12 Oct 2026, 5:44PM Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants ) Regulation, 2018 for the quarter ended 30th September, 20

  • Anuh Pharma - Trading Window

    28 Sep 2026, 4:38PM Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Anuh Pharma - Action(s) taken or orders passed

    18 Sep 2026, 4:02PM Anuh Pharma Limited has informed the Exchange about orders passed regarding receipt of Demand Order under Section 156 of the Income Tax Act, 1961.

  • Anuh Pharma Q1 net profit up 37.59% at Rs 11.42 cr

    22 Aug 2026, 6:00PM The company reported standalone net profit of Rs 11.42 crore for the quarter ended June 30, 2026 as compared to Rs 8.30 crore in the same period last

  • Anuh Pharma - Investor Presentation

    19 Aug 2026, 4:54PM Anuh Pharma Limited has informed the Exchange about Investor Presentation

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 Aug 2026, 4:47PM Investor Presentation for Q1 FY 2026-27

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    14 Aug 2026, 11:36PM Disclosure under Regulation 30 of SEBI (LODR), 2015 regarding Change in Management.

  • Anuh Pharma - Change in Management

    14 Aug 2026, 11:33PM Anuh Pharma Limited has informed the Exchange about change in Management

  • Anuh Pharma - Appointment

    14 Aug 2026, 11:32PM Anuh Pharma Limited has informed the Exchange regarding Appointment of Mr Bipin N. Shah, Mr. Arun L. Todarwal and Mr. Ankit Chande as Directors of the

  • Anuh Pharma - General Updates

    14 Aug 2026, 11:23PM Anuh Pharma Limited has informed the Exchange about General Updates under Regulation 30.

  • Anuh Pharma - Announcement Under Regulation 30 - General Updates

    14 Aug 2026, 11:20PM Disclosure of Announcement under Regulation 30 of SEBI (LODR), 2015

  • Anuh Pharma - Shareholders meeting

    14 Aug 2026, 10:45PM Anuh Pharma Limited has submitted the Exchange a copy Voting Results and Scrutinizers report of Annual General Meeting held on August 12, 2026.

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholders meeting

    12 Aug 2026, 9:13PM Anuh Pharma Limited has informed the Exchange regarding Proceedings of 66th Annual General Meeting held on August 12, 2026

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM

    12 Aug 2026, 9:09PM Outcome of the 66th Annual General Meeting of Anuh Pharma Limited held on Wednesday, 12th August, 2026

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    14 Aug 2026, 10:42PM Submission of Scrutinizer Report and Voting Results for the 66th Annual General Meeting of the Company

  • Anuh Pharma - Copy of Newspaper Publication

    9 Aug 2026, 4:48PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Unaudited financial results for the Quarter ended 30th June,

  • Anuh Pharma - Updates

    7 Aug 2026, 6:56PM Anuh Pharma Limited has informed the Exchange regarding 'Adoption of Revised Policy of Related Party Transactions.'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Adoption Of Revised Policy Of Related Party Transactions,

    7 Aug 2026, 6:52PM Adoption of Revised Policy of Related Party Transactions.

  • Anuh Pharma - Updates

    7 Aug 2026, 6:47PM Anuh Pharma Limited has informed the Exchange regarding 'Request received for Withdrawal of application for reclassification of shareholding from Prom

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Intimation Regarding The Request Received For Withdrawal Of Applicati

    7 Aug 2026, 6:44PM Request received for Withdrawal of application for reclassification of shareholding from \Promoter & Promoter Group' to 'Public Category'.

  • Anuh Pharma - Results - Financial Results For June 30, 2026

    7 Aug 2026, 6:32PM Unaudited Financial Results for the Quarter ended 30th June, 2026.

  • Anuh Pharma - Updates

    7 Aug 2026, 6:17PM Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'.

  • Anuh Pharma - Outcome of Board Meeting

    7 Aug 2026, 6:03PM Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

  • Anuh Pharma - Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/08/2026

    7 Aug 2026, 5:52PM To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter ended 30th June, 2026, Request received f

  • Anuh Pharma - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30

    3 Aug 2026, 4:42PM Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and appr

  • Anuh Pharma gets nod from WHO

    29 Sep 2020 , 10:28AM Anuh Pharma Ltd receives approval from WHO for Pyrimcthamine API
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anuh Pharma Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 352.2224 336.5229 293.2313 241.2214 216.8838
Liabilities 352.2224 336.5229 293.2313 241.2214 216.8838
Equity 50.112 25.056 25.056 25.056 25.056
Gross Profit 61.7203 60.9087 75.1491 51.2745 46.8455
Net Profit 41.0461 47.3519 60.0575 36.1796 30.5613
Cash From Operating Activities -3.0116 37.1248 12.9251 53.9016 28.8637
NPM(%) 5.31 7.15 9.28 6.85 6.27
Revenue 771.6574 661.5149 647.0043 527.486 486.6462
Expenses 709.9371 600.6062 571.8552 476.2115 439.8007
ROE(%) 11.28 13.02 16.51 9.94 8.4

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
05 Aug 2026 1.5 30 1.97 81.19
14 Aug 2025 1.5 30 1.97 207.39

Peers

Other companies within the same industry or sector that are comparable to Anuh Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 756.30 -3.57 19.13 45.14 -26.19 0.66
Lotus Eye Hospital and Institute Ltd 112.35 1.43 1605.00 164.48 0.39 0.00
Vaishali Pharma Ltd 7.04 -2.63 22.00 1031.82 15.42 0.00
Astec Lifesciences Ltd 645.75 -3.50 0.00 176.23 -363.14 0.00

Company Info

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1. 2025-The Company has issued Bonus Shares in the Ratio of 1:1.

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1. 2025-The Company has issued Bonus Shares in the Ratio of 1:1.

Parent Organisation

Anuh Pharma Ltd.

Founded

19/02/1960

Managing Director

Mr.Ritesh Shah

NSE Symbol

ANUHPHREQ

FAQ